Abstract

Underuse of glucose-lowering medications associated with cardiorenal protection in type 2 diabetes: from delayed initiation to untimely discontinuation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Could Sodium/Glucose Co-Transporter-2 Inhibitors Have Antiarrhythmic Potential in Atrial Fibrillation? Literature Review and Future Considerations.
Bernhard Reimers ... Konstantinos A Papathanasiou
Drugs | VOL. 81
Bernhard Reimers, et. al.Bernhard Reimers ... Konstantinos A Papathanasiou
23 Jul 2021
Therapeutic Advances in Diabetic Kidney Disease.
Panagiotis I Georgianos ... Theodoros Eleftheriadis
International journal of molecular sciences | VOL. 24
Panagiotis I Georgianos, et. al.Panagiotis I Georgianos ... Theodoros Eleftheriadis
01 Feb 2023
Population-based incidence of diabetic ketoacidosis in type 2 diabetes: medical claims data analysis in Japan.
Koji Kawakami ... Taichi Kawamura
Pharmacoepidemiology and drug safety | VOL. 27
Koji Kawakami, et. al.Koji Kawakami ... Taichi Kawamura
28 Jul 2017
Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence.
Gian Paolo Fadini ... Benedetta Maria Bonora
Diabetes, metabolic syndrome and obesity : targets and therapy | VOL. 13
Gian Paolo Fadini, et. al.Gian Paolo Fadini ... Benedetta Maria Bonora
01 Jan 2020
View more papers

More From: The Lancet regional health. Europe

Paper Title
Journal
Date
Author
Support not stigma: redefining perinatal mental health care.
The Lancet regional health. Europe | VOL. 40
01 May 2024
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study.
Eleanor Barnes ... Paul Moss
The Lancet regional health. Europe | VOL. 35
Eleanor Barnes, et. al.Eleanor Barnes ... Paul Moss
01 Dec 2023
The use of cannabidiol (CBD) as an analgesic component.
Andrew S.C Rice ... Kristian Kjær-Staal Petersen
The Lancet regional health. Europe | VOL. 35
Andrew S.C Rice, et. al.Andrew S.C Rice ... Kristian Kjær-Staal Petersen
01 Dec 2023
Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1. and XBB.1.5 in England.
Jamie Lopez Bernal ... Freja Cordelia Møller Kirsebom
The Lancet regional health. Europe | VOL. 35
Jamie Lopez Bernal, et. al.Jamie Lopez Bernal ... Freja Cordelia Møller Kirsebom
01 Dec 2023
View more papers